Saturday, August 27th, 2011
The U.S. Food and Drug Administration approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene. Xalkori is being approved with a companion diagnostic test that will help determine if a patient has ...
Posted in Health | Comments Off
Friday, May 6th, 2011
The challenges that medical device and diagnostic companies face in training and educating physicians and healthcare professionals on their products are extremely unique. Clinical trainers take on the difficult role of educating physicians and healthcare professionals on specific scientific, clinical, technical and procedural information surrounding a device or diagnostic technology...
Find ...
Posted in Health | Comments Off
Wednesday, May 4th, 2011
For large and small companies alike, sales teams are a critical component of the overall success of the organization and require specialized training and education on industry knowledge and sales methodologies. This conference program will highlight the best practices of leading organizations as they train, coach and develop sales executives ...
Posted in Health | Comments Off
Friday, March 4th, 2011
Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ...
Posted in Health | Comments Off
Tuesday, February 22nd, 2011
Tuberculosis (TB) remains one of the most pressing public health priorities for the 21st century, with over one third of the world population infected. Active TB disease is a major issue both for the patients who require specific treatment and at a population level, since these patients are contagious. Diagnosis ...
Posted in Health | Comments Off
